TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2022

Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy.

Mark H Rozenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.